HEADER UNKNOWN FUNCTION 01-NOV-19 6UV7 TITLE CRYSTAL STRUCTURE OF ALR1298, A PENTAPEPTIDE REPEAT PROTEIN FROM TITLE 2 NOSTOC PCC 7120, DETERMINED AT 2.3 ANGSTROM RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALR1298 PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: NOSTOC SP. (STRAIN PCC 7120 / SAG 25.82 / UTEX SOURCE 3 2576); SOURCE 4 ORGANISM_TAXID: 103690; SOURCE 5 STRAIN: PCC 7120 / SAG 25.82 / UTEX 2576; SOURCE 6 GENE: ALR1298; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PENTAPEPTIDE REPEAT, PROTEIN REPEAT, FIVE RESIDUE RIGHT-HANDED-BETA KEYWDS 2 HELIX, UNKNOWN FUNCTION EXPDTA X-RAY DIFFRACTION AUTHOR M.A.KENNEDY,R.ZHANG REVDAT 3 12-AUG-20 6UV7 1 JRNL REVDAT 2 11-MAR-20 6UV7 1 JRNL REVDAT 1 04-MAR-20 6UV7 0 JRNL AUTH R.ZHANG,S.NI,M.A.KENNEDY JRNL TITL CRYSTAL STRUCTURE OF ALR1298, A PENTAPEPTIDE REPEAT PROTEIN JRNL TITL 2 FROM THE CYANOBACTERIUM NOSTOC SP. PCC 7120, DETERMINED AT JRNL TITL 3 2.1 ANGSTROM RESOLUTION. JRNL REF PROTEINS V. 88 1143 2020 JRNL REFN ESSN 1097-0134 JRNL PMID 32092202 JRNL DOI 10.1002/PROT.25882 REMARK 2 REMARK 2 RESOLUTION. 2.27 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.13_2998 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.27 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.02 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 18077 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.204 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.251 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.990 REMARK 3 FREE R VALUE TEST SET COUNT : 1805 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 30.0200 - 5.3400 0.99 1356 150 0.1664 0.1965 REMARK 3 2 5.3400 - 4.2400 1.00 1288 142 0.1591 0.1889 REMARK 3 3 4.2400 - 3.7100 1.00 1265 142 0.1643 0.2338 REMARK 3 4 3.7100 - 3.3700 1.00 1267 140 0.2268 0.2781 REMARK 3 5 3.3700 - 3.1300 1.00 1253 139 0.2519 0.3129 REMARK 3 6 3.1300 - 2.9400 1.00 1232 136 0.2677 0.3663 REMARK 3 7 2.9400 - 2.8000 1.00 1234 137 0.2534 0.3574 REMARK 3 8 2.8000 - 2.6700 0.99 1240 137 0.2499 0.3226 REMARK 3 9 2.6700 - 2.5700 1.00 1234 137 0.2436 0.3039 REMARK 3 10 2.5700 - 2.4800 1.00 1237 137 0.2431 0.2816 REMARK 3 11 2.4800 - 2.4000 1.00 1212 135 0.2476 0.3168 REMARK 3 12 2.4000 - 2.3400 1.00 1243 137 0.2632 0.3336 REMARK 3 13 2.3400 - 2.2700 1.00 1211 136 0.3077 0.3630 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.338 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.981 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 55.91 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 71.46 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.014 2442 REMARK 3 ANGLE : 1.288 3282 REMARK 3 CHIRALITY : 0.055 368 REMARK 3 PLANARITY : 0.007 438 REMARK 3 DIHEDRAL : 15.517 1494 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6UV7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-NOV-19. REMARK 100 THE DEPOSITION ID IS D_1000245249. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-OCT-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 31-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97931 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.1 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18106 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.270 REMARK 200 RESOLUTION RANGE LOW (A) : 30.020 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : 0.02771 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.1800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.27 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.40 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 12.60 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: PHENIX 1.13_2998 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.32 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M AMMONIUM ACETATE, 0.1 M SODIUM REMARK 280 ACETATE TRIHYDRATE PH 4.6, 30% W/V POLYETHYLENE GLYCOL 4,000, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.92100 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 48.02350 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.18150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 48.02350 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.92100 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.18150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MSE A -19 REMARK 465 GLY A -18 REMARK 465 SER A -17 REMARK 465 SER A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 SER A -9 REMARK 465 SER A -8 REMARK 465 GLY A -7 REMARK 465 LEU A -6 REMARK 465 VAL A -5 REMARK 465 PRO A -4 REMARK 465 ARG A -3 REMARK 465 GLY A -2 REMARK 465 SER A -1 REMARK 465 HIS A 0 REMARK 465 MSE A 1 REMARK 465 ILE A 2 REMARK 465 MSE A 3 REMARK 465 ILE A 4 REMARK 465 ASN A 5 REMARK 465 PRO A 6 REMARK 465 HIS A 7 REMARK 465 THR A 8 REMARK 465 GLN A 9 REMARK 465 TYR A 162 REMARK 465 LEU A 163 REMARK 465 ALA A 164 REMARK 465 ASP A 165 REMARK 465 ASP A 166 REMARK 465 ASN A 167 REMARK 465 MSE B -19 REMARK 465 GLY B -18 REMARK 465 SER B -17 REMARK 465 SER B -16 REMARK 465 HIS B -15 REMARK 465 HIS B -14 REMARK 465 HIS B -13 REMARK 465 HIS B -12 REMARK 465 HIS B -11 REMARK 465 HIS B -10 REMARK 465 SER B -9 REMARK 465 SER B -8 REMARK 465 GLY B -7 REMARK 465 LEU B -6 REMARK 465 VAL B -5 REMARK 465 PRO B -4 REMARK 465 ARG B -3 REMARK 465 GLY B -2 REMARK 465 SER B -1 REMARK 465 HIS B 0 REMARK 465 MSE B 1 REMARK 465 ILE B 2 REMARK 465 MSE B 3 REMARK 465 ILE B 4 REMARK 465 ASN B 5 REMARK 465 PRO B 6 REMARK 465 HIS B 7 REMARK 465 THR B 8 REMARK 465 LEU B 163 REMARK 465 ALA B 164 REMARK 465 ASP B 165 REMARK 465 ASP B 166 REMARK 465 ASN B 167 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 11 -48.92 -161.48 REMARK 500 GLU A 32 11.42 -67.62 REMARK 500 ASN A 60 67.27 73.38 REMARK 500 MSE A 64 -53.79 -122.70 REMARK 500 LYS A 65 -2.62 55.21 REMARK 500 LYS A 116 -0.22 69.35 REMARK 500 ASN A 143 99.35 -29.18 REMARK 500 ASP B 10 126.56 97.86 REMARK 500 GLU B 91 17.93 58.42 REMARK 500 REMARK 500 REMARK: NULL DBREF 6UV7 A 1 167 UNP Q8YXB7 Q8YXB7_NOSS1 1 167 DBREF 6UV7 B 1 167 UNP Q8YXB7 Q8YXB7_NOSS1 1 167 SEQADV 6UV7 MSE A -19 UNP Q8YXB7 INITIATING METHIONINE SEQADV 6UV7 GLY A -18 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 SER A -17 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 SER A -16 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 HIS A -15 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 HIS A -14 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 HIS A -13 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 HIS A -12 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 HIS A -11 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 HIS A -10 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 SER A -9 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 SER A -8 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 GLY A -7 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 LEU A -6 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 VAL A -5 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 PRO A -4 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 ARG A -3 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 GLY A -2 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 SER A -1 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 HIS A 0 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 MSE A 89 UNP Q8YXB7 LEU 89 CONFLICT SEQADV 6UV7 MSE A 124 UNP Q8YXB7 LEU 124 CONFLICT SEQADV 6UV7 GLU A 159 UNP Q8YXB7 LYS 159 CONFLICT SEQADV 6UV7 MSE B -19 UNP Q8YXB7 INITIATING METHIONINE SEQADV 6UV7 GLY B -18 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 SER B -17 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 SER B -16 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 HIS B -15 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 HIS B -14 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 HIS B -13 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 HIS B -12 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 HIS B -11 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 HIS B -10 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 SER B -9 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 SER B -8 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 GLY B -7 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 LEU B -6 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 VAL B -5 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 PRO B -4 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 ARG B -3 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 GLY B -2 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 SER B -1 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 HIS B 0 UNP Q8YXB7 EXPRESSION TAG SEQADV 6UV7 MSE B 89 UNP Q8YXB7 LEU 89 CONFLICT SEQADV 6UV7 MSE B 124 UNP Q8YXB7 LEU 124 CONFLICT SEQADV 6UV7 GLU B 159 UNP Q8YXB7 LYS 159 CONFLICT SEQRES 1 A 187 MSE GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 187 LEU VAL PRO ARG GLY SER HIS MSE ILE MSE ILE ASN PRO SEQRES 3 A 187 HIS THR GLN ASP ILE ARG SER GLN SER ILE HIS PHE LEU SEQRES 4 A 187 GLU GLN SER PRO SER GLU ARG LEU GLN ILE LEU GLN GLU SEQRES 5 A 187 LEU GLY LEU GLY ARG PHE LYS PHE LEU SER LYS ILE ARG SEQRES 6 A 187 LEU ASN ASP SER ASN VAL ASP CYS VAL ILE ARG PHE PHE SEQRES 7 A 187 GLN ASN PRO GLY GLN MSE LYS PHE PRO ASN LEU SER GLY SEQRES 8 A 187 ALA ASP LEU SER GLU LEU ASN LEU ASP GLU VAL SER LEU SEQRES 9 A 187 ILE ARG GLY ASN MSE SER GLU ALA ASN LEU GLN GLY SER SEQRES 10 A 187 SER LEU LEU ASN ALA ASP LEU ILE PHE VAL ASN PHE THR SEQRES 11 A 187 LYS ALA ASP LEU ARG LYS ALA ASP LEU ARG GLY ALA THR SEQRES 12 A 187 MSE ASN GLY THR VAL TRP LEU ASP THR LEU VAL ASP GLU SEQRES 13 A 187 CYS GLN LEU GLY ILE GLY ASN GLY LEU THR LYS GLN GLN SEQRES 14 A 187 ARG LYS ASP LEU GLN LEU ARG GLY ALA GLU PHE ASN TYR SEQRES 15 A 187 LEU ALA ASP ASP ASN SEQRES 1 B 187 MSE GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 187 LEU VAL PRO ARG GLY SER HIS MSE ILE MSE ILE ASN PRO SEQRES 3 B 187 HIS THR GLN ASP ILE ARG SER GLN SER ILE HIS PHE LEU SEQRES 4 B 187 GLU GLN SER PRO SER GLU ARG LEU GLN ILE LEU GLN GLU SEQRES 5 B 187 LEU GLY LEU GLY ARG PHE LYS PHE LEU SER LYS ILE ARG SEQRES 6 B 187 LEU ASN ASP SER ASN VAL ASP CYS VAL ILE ARG PHE PHE SEQRES 7 B 187 GLN ASN PRO GLY GLN MSE LYS PHE PRO ASN LEU SER GLY SEQRES 8 B 187 ALA ASP LEU SER GLU LEU ASN LEU ASP GLU VAL SER LEU SEQRES 9 B 187 ILE ARG GLY ASN MSE SER GLU ALA ASN LEU GLN GLY SER SEQRES 10 B 187 SER LEU LEU ASN ALA ASP LEU ILE PHE VAL ASN PHE THR SEQRES 11 B 187 LYS ALA ASP LEU ARG LYS ALA ASP LEU ARG GLY ALA THR SEQRES 12 B 187 MSE ASN GLY THR VAL TRP LEU ASP THR LEU VAL ASP GLU SEQRES 13 B 187 CYS GLN LEU GLY ILE GLY ASN GLY LEU THR LYS GLN GLN SEQRES 14 B 187 ARG LYS ASP LEU GLN LEU ARG GLY ALA GLU PHE ASN TYR SEQRES 15 B 187 LEU ALA ASP ASP ASN MODRES 6UV7 MSE A 64 MET MODIFIED RESIDUE MODRES 6UV7 MSE B 64 MET MODIFIED RESIDUE HET MSE A 64 17 HET MSE A 89 17 HET MSE A 124 17 HET MSE B 64 17 HET MSE B 89 17 HET MSE B 124 17 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 6(C5 H11 N O2 SE) FORMUL 3 HOH *17(H2 O) HELIX 1 AA1 ILE A 11 GLU A 20 1 10 HELIX 2 AA2 SER A 22 GLU A 32 1 11 HELIX 3 AA3 LEU A 33 LYS A 43 5 11 HELIX 4 AA4 ASN A 47 GLN A 59 1 13 HELIX 5 AA5 THR A 146 ARG A 156 1 11 HELIX 6 AA6 ASP B 10 GLU B 20 1 11 HELIX 7 AA7 SER B 22 LEU B 33 1 12 HELIX 8 AA8 PHE B 38 LYS B 43 5 6 HELIX 9 AA9 ASN B 47 ASN B 60 1 14 HELIX 10 AB1 THR B 146 ARG B 156 1 11 SHEET 1 AA1 2 GLN A 138 GLY A 140 0 SHEET 2 AA1 2 GLU A 159 PHE A 160 1 O GLU A 159 N LEU A 139 SHEET 1 AA2 2 GLN B 138 GLY B 140 0 SHEET 2 AA2 2 GLU B 159 PHE B 160 1 O GLU B 159 N LEU B 139 LINK C GLN A 63 N MSE A 64 1555 1555 1.34 LINK C MSE A 64 N LYS A 65 1555 1555 1.34 LINK C ASN A 88 N MSE A 89 1555 1555 1.32 LINK C MSE A 89 N SER A 90 1555 1555 1.31 LINK C THR A 123 N MSE A 124 1555 1555 1.34 LINK C MSE A 124 N ASN A 125 1555 1555 1.33 LINK C GLN B 63 N MSE B 64 1555 1555 1.33 LINK C MSE B 64 N LYS B 65 1555 1555 1.34 LINK C ASN B 88 N MSE B 89 1555 1555 1.32 LINK C MSE B 89 N SER B 90 1555 1555 1.32 LINK C THR B 123 N MSE B 124 1555 1555 1.32 LINK C MSE B 124 N ASN B 125 1555 1555 1.34 CRYST1 45.842 86.363 96.047 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021814 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011579 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010412 0.00000